Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>News>This Article

ChemAxon Major Software Release brings New Desktop, Web and Visualization Applications to Power Chemistry Decision Making

Published: Thursday, May 30, 2013
Last Updated: Thursday, May 30, 2013
Bookmark and Share
New version sets the standard in chemistry software for scientists and IT infrastructure.

ChemAxon announces Version 6 of their cheminformatics suite. This major software release introduces four new products:  Marvin for JavaScript, Instant JChem Web Client, REST Web Services, and the Plexus project, a public beta of a web-based discovery application for bench scientists. In addition, Version 6 sees a raft of enhancements across the ChemAxon Marvin/JChem product suite improving user experience, computational performance and collaboration support, and enabling more effective chemistry data management.

Version 6 for scientists:
•    All GUIs are refreshed to simplify both the user experience and access to key chemistry functions
•    Marvin for JavaScript - new light-weight chemical editor for web pages which does not require Java
•    Plexus - new web-based application for medicinal and computational chemists, featuring dynamic data visualization
•    Improved integration with Microsoft Office
Version 6 for enterprise IT:
•    Instant JChem Web Client - enables Instant JChem data visualization forms to be easily made available and worked with as Web pages
•    New REST Web Services to complement existing SOA Web Services
•    New search features and indexing support for ISIS and ChemDraw Excel workbooks in JChem for SharePoint
•    Enhanced compound registration capabilities, including project-related data storage
“Research-based organizations need to support increasingly diverse and distributed R&D environments,” commented Alex Drijver, CEO of ChemAxon. “The Version 6 release deepens our core chemistry and technical capabilities, and focuses on making that functionality more relevant to researchers’ processes with improved usability and new collaboration and analysis interfaces.”

ChemAxon software is adopted by a diverse customer base to support and accelerate the process from initial concept to new product candidate, minimizing IT overheads. The software suite offers robust, scalable and flexible chemistry information management that is easily aligned with organizations’ business processes. ChemAxon’s client base includes all of the top 15 global pharma companies, major chemical and agrochemistry companies, innovative biotechnology enterprises and academic research centres world-wide.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

ChemAxon Provides Chemistry Informatics Platform for the European Lead Factory
ChemAxon will provide the core tools to support the pan European initiative.
Tuesday, June 18, 2013
ChemAxon Extends Free Service with Predicted Data and User Customization
The new features help users understand better the chemical structure with more predicted properties and a customizable layout.
Monday, August 23, 2010
Broad Institute Acquires License to all ChemAxon Products and Deploys Across Chemical Biology Platform
License covers ChemAxon’s platform, discovery toolkits and desktop applications for institute-wide use.
Friday, August 20, 2010
ChemAxon Announces new CEO and Head of R&D
Company increases its focus on business development and market position with new appointments.
Tuesday, May 13, 2008
Migrating Chemical Information to New Architectures
New ChemAxon whitepaper discusses the drivers behind the increasing number of pharma and biotech companies moving from traditional proprietary chemical information systems to modern alternatives.
Monday, January 29, 2007
Scientific News
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Chemical Design Made Easier
Rice University scientists prepare elusive organocatalysts for drug and fine chemical synthesis.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Fighting Pain with Ketamine
Researchers at the Texas A&M Health Science Center are using ketamine, a drug that already exists as an anesthetic, to treat pain.
Possible New Treatment for Neurodegenerative Diseases Found
Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be used as a treatment for neurodegenerative diseases.
Breast Cancer Drug Beats Superbug
Tamoxifen helps white blood cells clear multidrug-resistant bacteria in lab and mouse studies.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos